Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Rothstein

Showing results (251-260 of 260) with videos related to

Pageof 26
Sort By:
You have reached the last page of results.This site can display upto 260 results.
Oncotarget|August 18, 2016
Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancerShalaka S Hampras, Lara E Sucheston-Campbell, Rikki Cannioto, et al.
Genetic Epidemiology|September 25, 2015
Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) RiskErnest K Amankwah, Hui-Yi Lin, Jonathan P Tyrer, et al.
Plos One|June 20, 2015
Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) RiskGanna Chornokur, Hui-Yi Lin, Jonathan P Tyrer, et al.
Nature Communications|September 23, 2015
Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancerKate Lawrenson, Qiyuan Li, Siddhartha Kar, et al.
JAMA Pediatrics|January 27, 2016
Global and National Burden of Diseases and Injuries Among Children and Adolescents Between 1990 and 2013: Findings From the Global Burden of Disease 2013 Study, Hmwe H Kyu, Christine Pinho, et al.
Nature Genetics|January 13, 2015
Identification of six new susceptibility loci for invasive epithelial ovarian cancerKaroline B Kuchenbaecker, Susan J Ramus, Jonathan Tyrer, et al.
Journal of Medical Genetics|September 7, 2016
PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGSMelissa C Southey, David E Goldgar, Robert Winqvist, et al.
Gynecologic Oncology|May 6, 2015
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer, Antoinette Hollestelle, Frederieke H van der Baan, et al.
Nature Genetics|March 28, 2017
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancerCatherine M Phelan, Karoline B Kuchenbaecker, Jonathan P Tyrer, et al.
Lancet (London, England)|September 1, 2015
Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition, Christopher J L Murray, Ryan M Barber, et al.
Pageof 26

Showing results (251-260 of 260) with videos related to

Sort By:
Pageof 26
You have reached the last page of results.This site can display upto 260 results.
Oncotarget|August 18, 2016
Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancerShalaka S Hampras, Lara E Sucheston-Campbell, Rikki Cannioto, et al.
Genetic Epidemiology|September 25, 2015
Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) RiskErnest K Amankwah, Hui-Yi Lin, Jonathan P Tyrer, et al.
Plos One|June 20, 2015
Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) RiskGanna Chornokur, Hui-Yi Lin, Jonathan P Tyrer, et al.
Nature Communications|September 23, 2015
Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancerKate Lawrenson, Qiyuan Li, Siddhartha Kar, et al.
JAMA Pediatrics|January 27, 2016
Global and National Burden of Diseases and Injuries Among Children and Adolescents Between 1990 and 2013: Findings From the Global Burden of Disease 2013 Study, Hmwe H Kyu, Christine Pinho, et al.
Nature Genetics|January 13, 2015
Identification of six new susceptibility loci for invasive epithelial ovarian cancerKaroline B Kuchenbaecker, Susan J Ramus, Jonathan Tyrer, et al.
Journal of Medical Genetics|September 7, 2016
PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGSMelissa C Southey, David E Goldgar, Robert Winqvist, et al.
Gynecologic Oncology|May 6, 2015
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer, Antoinette Hollestelle, Frederieke H van der Baan, et al.
Nature Genetics|March 28, 2017
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancerCatherine M Phelan, Karoline B Kuchenbaecker, Jonathan P Tyrer, et al.
Lancet (London, England)|September 1, 2015
Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition, Christopher J L Murray, Ryan M Barber, et al.
Pageof 26